Glass House Brands Reports Second Quarter 2026 Financial Results
Detailed price information for Glass House Brands Inc (GLAS-N) from The Globe and Mail including charting and trades.
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Our AI ranks Glass House Brands Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Glass House Brands Inc. is a small-cap company with a market capitalization of $301M. It ranks number 7 by market capitalization among the 28 Medicinal Chemicals & Botanical Products issuers in our coverage with a current forecast.
For GLAS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 39 forecast dates between 2026-05-26 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 40.0%, measured on 82 forecast dates between 2026-05-26 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, GLAS included.
Follow GLAS free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Medicinal Chemicals & Botanical Products peers listed below that report each metric.
| Metric | GLAS | Rank |
|---|---|---|
| Market Cap | $301M | 7/28 |
| P/B Ratio | 4.07x | 3/13 |
| Book Value/Share | $0.78 | – |
| Metric | GLAS | Rank |
|---|---|---|
| ROE | -33.9% | 9/16 |
| ROA | -7.9% | 10/24 |
| Net Margin | -17.8% | 12/22 |
| Metric | GLAS | Rank |
|---|---|---|
| Current Ratio | 1.78x | 11/28 |
| Quick Ratio | 1.09x | 10/26 |
| D/E Ratio | 1.95x | 4/17 |
| Financial Leverage | 4.31x | 2/17 |
| Interest Coverage | -3.6x | 14/22 |
| Working Capital | $30M | 12/28 |
| Metric | GLAS | Rank |
|---|---|---|
| Net Income | -$25M | 17/24 |
| Metric | GLAS | Rank |
|---|---|---|
| Shares Outstanding | 94M | – |
| Total Current Assets | $68M | 21.3% of assets |
| Cash & Short-term Investments | $23M | 7.3% of assets |
| Accounts Receivable | $4M | 1.4% of assets |
| Inventory | $26M | 8.2% of assets |
| Total Liabilities | $144M | 45.2% of assets |
| Short-term Debt | $24M | 7.6% of assets |
Companies classified under the same SEC industry code as Glass House Brands Inc. (Medicinal Chemicals & Botanical Products): 32 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| GLAS Glass House Brands Inc. | ▼ | $301M |
| DFTX Definium Therapeutics, Inc. | ▲ | $4.31B |
| TRLV Trulieve Cannabis Corp. | ▲ | $1.98B |
| CRON Cronos Group Inc. | ▶ | $1.18B |
| TLRY Tilray Brands, Inc. | ▼ | $437M |
| SNDL Sndl Inc. | ▶ | $312M |
| CGC Canopy Growth Corp | ▶ | $302M |
| USNA Usana Health Sciences Inc | ▼ | $284M |
| ACB Aurora Cannabis Inc | ▶ | $253M |
| NAGE Niagen Bioscience, Inc. | ▶ | $204M |
| MDWD Mediwound Ltd. | ▶ | $157M |
| AAWH Ascend Wellness Holdings, Inc. | ▲ | $83M |
| FTLF Fitlife Brands, Inc. | ▲ | $81M |
| BTMD Biote Corp. | ▲ | $32M |
| MRMD Marimed Inc. | ▲ | $23M |
| CFOO China Foods Holdings Ltd. | ▼ | $21M |
| MTEX Mannatech Inc | ▲ | $14M |
| ADIA Adia Med, Inc. | ▲ | $13M |
| CHUC Charlie's Holdings, Inc. | ▼ | $13M |
| GLUC Glucose Health, Inc. | ▼ | $10M |
| BON Bon Natural Life Ltd | ▶ | $7M |
| NAII Natural Alternatives International Inc | ▲ | $7M |
| PLSH Panacea Life Sciences Holdings, Inc. | ▲ | $6M |
| CYAN Cyanotech Corp | ▲ | $5M |
| IMCC Im Cannabis Corp. | ▼ | $2M |
| AIBT Aibotics, Inc. | ▼ | $2M |
| NPHC Nutra Pharma Corp | ▼ | $720K |
| MEHA Functional Brands Inc. | ▼ | $310K |
| CBDY Target Group Inc. | ▼ | N/A |
| HYEX Healthy Extracts Inc. | ▲ | N/A |
| NTRR Neutra Corp. | ▼ | N/A |
| SNYRQ Synergy Chc Corp. | ▼ | N/A |
Detailed price information for Glass House Brands Inc (GLAS-N) from The Globe and Mail including charting and trades.
GACP Certification from Perry Johnson Supports Pathway to International MarketsThis news release constitutes a 'designated news release' for the ...
Good afternoon, ladies and gentlemen. Welcome to the Glass House Brands First Quarter 2026 Earnings Call. Matters discussed today during today's conference call may constitute forward-looking ...
Our AI ranks Glass House Brands Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
For GLAS, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 39 forecast dates between 2026-05-26 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 40.0%, measured on 82 forecast dates between 2026-05-26 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Glass House Brands Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
32 issuers in our coverage, GLAS included, share the SEC industry code Medicinal Chemicals & Botanical Products. The largest are: Definium Therapeutics, Inc. (DFTX), Trulieve Cannabis Corp. (TRLV), Cronos Group Inc. (CRON), Tilray Brands, Inc. (TLRY), Sndl Inc. (SNDL), Canopy Growth Corp (CGC).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.